Megaloblastic Hematopoiesis in Uremia and in Patients on Long-Term Hemodialysis
- 9 March 1967
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 276 (10) , 551-554
- https://doi.org/10.1056/nejm196703092761005
Abstract
SEVERE chronic renal failure has an adverse effect on hematopoiesis.1 The major defect appears to be one of relative bone-marrow failure in that the marrow of the patient with uremia does not respond to anemic stress to the same extent as normal marrow.2 The role of erythropoietin in this bone-marrow failure is in doubt.2 It may be that circulating "toxins" play a major part and depress the marrow directly.3 , 4 Another possibility is nutritional deficiency or a deranged metabolism of vitamins in uremic patients. Many marrows that we have examined in patients with chronic renal failure appear megaloblastic, particularly in the . . .This publication has 10 references indexed in Scilit:
- current evaluation of human kidney transplantation*Annals of the New York Academy of Sciences, 2006
- Hemodialysis: A Successful Therapy for Chronic UremiaAnnals of Internal Medicine, 1966
- Aseptic addition method for Lactobacillus casei assay of folate activity in human serumJournal of Clinical Pathology, 1966
- Megaloblastic anemias-mechanisms & managementDisease-a-Month, 1965
- Erythropoiesis in Anephric Man *Journal of Clinical Investigation, 1964
- EVIDENCE FOR PRESENCE OF SUBSTANCES TOXIC FOR HELA CELLS IN SERUM + IN DIALYSIS FLUID OF PATIENTS WITH GLOMERULONEPHRITIS1964
- THE RENAL EXCRETION OF FOLIC ACID*Journal of Clinical Investigation, 1963
- Measurement of Blood Volume with a New ApparatusNew England Journal of Medicine, 1961
- The Anemia of Renal FailureArchives of internal medicine (1960), 1958
- Co60 Vitamin B12 Binding Capacity of Normal Human Serum.Experimental Biology and Medicine, 1957